JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) PB Ratio : 0.47 (As of May. 15, 2024)

View and export this data going back to 2021. Start your Free Trial

What is JW (Cayman) Therapeutics Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-15), JW (Cayman) Therapeutics Co's share price is $0.2703. JW (Cayman) Therapeutics Co's Book Value per Share for the quarter that ended in Dec. 2023 was $0.57. Hence, JW (Cayman) Therapeutics Co's PB Ratio of today is 0.47.

The historical rank and industry rank for JW (Cayman) Therapeutics Co's PB Ratio or its related term are showing as below:

JWCTF' s PB Ratio Range Over the Past 10 Years
Min: 0.29 Med: 0.51 Max: 1.6
Current: 0.54

During the past 6 years, JW (Cayman) Therapeutics Co's highest PB Ratio was 1.60. The lowest was 0.29. And the median was 0.51.

JWCTF's PB Ratio is ranked better than
90.85% of 1312 companies
in the Biotechnology industry
Industry Median: 2.48 vs JWCTF: 0.54

During the past 12 months, JW (Cayman) Therapeutics Co's average Book Value Per Share Growth Rate was -30.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -24.80% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of JW (Cayman) Therapeutics Co was -24.80% per year. The lowest was -24.80% per year. And the median was -24.80% per year.

Back to Basics: PB Ratio

JW (Cayman) Therapeutics Co PB Ratio Historical Data

The historical data trend for JW (Cayman) Therapeutics Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW (Cayman) Therapeutics Co PB Ratio Chart

JW (Cayman) Therapeutics Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

1.85

0.61

0.47

JW (Cayman) Therapeutics Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PB Ratio	Get a 7-Day Free Trial						1.85	1.06	0.61	0.52	0.47

Competitive Comparison of JW (Cayman) Therapeutics Co's PB Ratio

For the Biotechnology subindustry, JW (Cayman) Therapeutics Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JW (Cayman) Therapeutics Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JW (Cayman) Therapeutics Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where JW (Cayman) Therapeutics Co's PB Ratio falls into.

JW (Cayman) Therapeutics Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

JW (Cayman) Therapeutics Co's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	0.2703	/	0.572
	=	0.47

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

JW (Cayman) Therapeutics Co (OTCPK:JWCTF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

JW (Cayman) Therapeutics Co PB Ratio Related Terms

Thank you for viewing the detailed overview of JW (Cayman) Therapeutics Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (OTCPK:JWCTF) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

02126:Hong Kong

Address

No. 699 Zhong Ke Road, 5F, Building B, Pudong New District, Shanghai, CHN

Website

https://www.jwtherapeutics.com

JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Headlines

No Headlines